13FPulse
中
HR

HROW HARROW INC

2026Q2 · CUSIP 415858109 · Sector: Healthcare & Biotech

Normal

Fund flows are within the usual range

Funds that own it
221
Institutions that reported holding it to the SEC
Net increase in holders
+5
Last quarter 216 → now 221
How unusual is that
Above average
Stronger buying than 56% of US stocks
What the filings say, in one paragraph

221 funds held HROW at the end of 2026Q2, up 5 from the quarter before. Fund flows are within the usual range — nothing unusual. On the business itself, revenue over the last 12 months was $276M(YoY +21.1%), return on equity is -244.9%. HROW has had 6 buying rushes in its history, and the price moved +21.6% on average over the six months after (that is the raw price move, not how much it beat the market by). It sits in the Healthcare & Biotech sector.

How many funds owned it, quarter by quarter

Bars = net change in institutional holders, positive (green) or negative (red). Line = total institutional holders.

2019Q1: holders=53 2019Q2: holders=52 2019Q3: holders=53 2019Q4: holders=59 2020Q1: holders=56 2020Q2: holders=69 2020Q3: holders=73 2020Q4: holders=79 2021Q1: holders=92 2021Q2: holders=90 2021Q3: holders=79 2021Q4: holders=77 2022Q1: holders=79 2022Q2: holders=88 2022Q3: holders=81 2022Q4: holders=96 2023Q1: holders=115 2023Q2: holders=111 2023Q3: holders=129 2023Q4: holders=113 2024Q1: holders=113 2024Q2: holders=110 2024Q3: holders=159 2024Q4: holders=166 2025Q1: holders=156 2025Q2: holders=160 2025Q3: holders=197 2025Q4: holders=215 2026Q1: holders=216 2026Q2: holders=221 -49 -24.5 +0 +24.5 +49 46140233 19Q119Q420Q321Q222Q122Q423Q324Q225Q125Q426Q2 Net change in holders (bars) Total funds holding (line)

What happened after each past buying rush 6 times in its history

Quarter of the rush How unusual then Price, next 3 months Price, next 6 months
2025Q3 Top 10% +26.1% -23.4%
2024Q3 Top 5% -23.8% -32.2%
2023Q3 Top 10% +33.6% +95.2%
2023Q1 Top 10% -21.9% -62.5%
2022Q2 Top 20% +33.9% +131.1%
2019Q1 Top 5% — —

These are the raw price moves, not how much it beat the market by. Compare them against the market over the same months — in a strong bull market almost everything is up.

Show all the numbers (large funds, value held, options…) ▾
Of them, large funds
110
Change in large funds
+8
Total value they hold
$911M
Funds buying for the first time
43
Funds that sold out entirely
38
Price change that quarter
+26.4%
Funds holding puts (bearish)
5
Funds holding calls (bullish)
4

These are for people who want to dig. Skip them if they do not mean anything to you — the three numbers above are enough.

8,697 institutions have filed for this quarter. 13F permits late filing and a small number arrive in the weeks after the deadline, so the holder counts and changes below may tick up.

Fundamentals

PE (TTM)
—
EPS (TTM)
$-0.97
EPS YoY
—
Revenue (TTM)
$0.3B
Revenue YoY
+21.1%
Net margin
-13.5%
ROE
-244.9%
Debt ratio
96.4%
FCF (TTM)
$5M
Dividend (TTM)
No dividend
Quarterly Revenue & EPS
2021-09-30: EPS -0.31 2021-12-31: EPS -0.28 2022-03-31: EPS -0.09 2022-06-30: EPS -0.23 2022-09-30: EPS -0.24 2022-12-31: EPS 0.05 2023-03-31: EPS -0.22 2023-06-30: EPS -0.14 2023-09-30: EPS -0.13 2023-12-31: EPS -0.26 2024-03-31: EPS -0.38 2024-06-30: EPS -0.18 2024-09-30: EPS -0.12 2024-12-31: EPS 0.19 2025-03-31: EPS -0.50 2025-06-30: EPS 0.13 2025-09-30: EPS 0.03 2025-12-31: EPS 0.20 2026-03-31: EPS -0.74 2026-06-30: EPS -0.46 0M 45M 89M $M -0.81 -0.30 0.22 2016201720182019202020212022202320242025202606/26 Revenue EPS

Quarterly figures, revenue up to 10 years back; EPS split-adjusted, early quarters hidden when not calibrable

Quarterly free cash flow
-18M582K19M 20162017201820192020202120222023202420252026
Latest quarter $-9M (2026-03-31)

FCF = operating cash flow − capex, computed from SEC XBRL; banks/insurers have no standard cash-flow structure and are hidden

As of 2026-06-30 · SEC filings (XBRL)

Email me the next update

2026 Q3 holdings are due 2026-11-16. We will email you when the refreshed lists are live.